SECsense Logo

NeuroOne Medical Technologies 8-K Report - Key Updates (Jan 10, 2025)

$NMTC
Form 8-K
Filed on: 2025-01-10
Source
NeuroOne Medical Technologies 8-K Report - Key Updates (Jan 10, 2025)

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Name: NeuroOne Medical Technologies Corporation
  • CIK: 0001500198
  • SEC File Number: 001-40439
  • EIN: 27-0863354
  • Address: 7599 Anagram Dr., Eden Prairie, MN 55344
  • Contact: 952-426-1383
  1. Filing Type:
  • Form Type: 8-K
  • Filing Date: January 10, 2025
  1. Stock Information:
  • Common Stock: Par value of $0.001 per share
  • Ticker Symbol: NMTC
  • Exchange: NASDAQ
  1. Reporting Period:
  • Date of Report: January 10, 2025 (the start and end date of the reporting period are the same).
  1. Units of Measurement:
  • The report utilizes USD (U.S. Dollars) for monetary values and shares for stock metrics.
  1. Metadata:
  • The XML schema reference indicates that the document is formatted according to XBRL standards, which is a common format used for financial reporting.

Insights:

  • Nature of Filing: An 8-K filing typically indicates that the company is reporting on significant events that shareholders should be aware of. This could involve changes in management, acquisitions, or other major developments.
  • Stock Characteristics: The company's common stock is listed on NASDAQ, indicating it is a publicly traded entity, which will be subject to SEC regulations and reporting requirements.
  • Location and Contact: The address and contact number provide a means for stakeholders to reach out for further information, which is critical for transparency and investor relations.

This information can be essential for investors, analysts, and stakeholders assessing the company's current standing and any significant events that may impact its future performance.